Symbiox Investment & Trading Complete Financial Statements
In FY2015, Symbiox Investment & Trading (SYMBIOX) reported revenue ₹1 Cr, net profit ₹0 Cr and EPS ₹0.01. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review SYMBIOX earnings multiple to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SYMBIOX Revenue, Net Profit & EBITDA — Year-on-Year Growth
SYMBIOX YoY. For live price, earnings ratios and company overview, see SYMBIOX stock price BSE.
SYMBIOX Income Statement — Revenue, EBITDA & Net Profit
Symbiox Investment & Trading revenue ₹1 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.01 (2015). Explore SYMBIOX Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
| Particulars | Mar 2015 |
|---|---|
| Revenue | 1 |
| Expenses | 1 |
| EBITDA | 0 |
| Operating Profit Margin % | 0.00% |
| Depreciation | 0 |
| Interest | 0 |
| Profit Before Tax | 0 |
| Tax | 0 |
| Net Profit | 0 |
| Earnings Per Share (₹) | 0.01 |
SYMBIOX Balance Sheet — Assets, Liabilities & Shareholders' Equity
SYMBIOX total assets ₹32 Cr, total equity ₹32 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 32 | 32 | 32 | 33 | 32 | 33 | 32 | 34 | 33 | 32 | 31 | 31 |
| Current Assets | 32 | 32 | 32 | 33 | 32 | 33 | 32 | 34 | 33 | 32 | 31 | 31 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 13 | 10 | 13 | 18 | 18 | 17 | 17 | 15 | 15 | 13 | 30 |
| Other Assets | 0 | 19 | 22 | 20 | 14 | 15 | 15 | 17 | 17 | 17 | 18 | 1 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 32 | 32 | 32 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Share Capital | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves & Surplus | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 |
SYMBIOX Cash Flow Statement — Operating, Investing & Financing
Symbiox Investment & Trading operating cash flow ₹4 Cr, investing ₹-3 Cr, financing ₹0 Cr, net cash flow ₹1 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 4 | -3 | -5 | 0 | 1 | 0 | 1 | 1 | 2 | -17 | -1 |
| Investing Activities | -3 | 3 | 5 | 0 | -1 | 0 | -2 | 0 | -1 | 17 | 1 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |